---
title: "WHO Condemns US-Funded Newborn Vaccine Trial as Unethical"
date: 2026-02-14T06:50:36-05:00
author: "US News Desk"
categories: ["Health"]
tags: ["vaccine trial"]
featured_image: "/images/default-news.jpg"
description: "WHO slams US-funded vaccine trial"
draft: false
---

## Key Takeaways
* The World Health Organization (WHO) has condemned a US-funded newborn vaccine trial as "unethical".
* The trial, which is set to take place in Guinea-Bissau, aims to test the effectiveness of a hepatitis B vaccine in newborn babies.
* The WHO has raised concerns about the trial's methodology and the potential risks it poses to the participating infants.
* Lawmakers have called for answers on the trial, citing concerns about the ethics and safety of the study.
* The controversy surrounding the trial has sparked a wider debate about the ethics of medical research and the need for greater transparency and accountability.

## Introduction
The World Health Organization (WHO) has sparked a heated debate in the medical community by condemning a US-funded newborn vaccine trial as "unethical". The trial, which is set to take place in Guinea-Bissau, aims to test the effectiveness of a hepatitis B vaccine in newborn babies. However, the WHO has raised concerns about the trial's methodology and the potential risks it poses to the participating infants. In this article, we will delve into the details of the controversy and explore the implications of the WHO's condemnation.

The trial in question is a randomized controlled trial, which means that some newborn babies will receive the hepatitis B vaccine, while others will receive a placebo. The study aims to determine whether the vaccine is effective in preventing hepatitis B infection in newborns. However, the WHO has raised concerns about the trial's design, citing the potential risks of withholding the vaccine from some participants. The organization has also questioned the informed consent process, citing concerns that the parents of the participating infants may not fully understand the risks and benefits of the trial.

## Background & Context
The hepatitis B vaccine is a widely used and effective vaccine that has been shown to prevent hepatitis B infection in individuals of all ages. However, the vaccine is typically administered in a series of doses, with the first dose given at birth. The trial in question aims to test the effectiveness of a single dose of the vaccine in preventing hepatitis B infection in newborns.

The trial is being funded by the US Centers for Disease Control and Prevention (CDC), which has sparked controversy among lawmakers and medical experts. Some have questioned the ethics of the trial, citing concerns about the potential risks to the participating infants. Others have raised concerns about the methodology of the trial, citing concerns about the lack of transparency and accountability.

### The Role of the WHO
The WHO has played a crucial role in the controversy surrounding the trial. The organization has a long history of promoting public health and safety, and has been a vocal advocate for the rights of patients and research participants. The WHO's condemnation of the trial has sparked a wider debate about the ethics of medical research and the need for greater transparency and accountability.

## Analysis
The controversy surrounding the trial has significant implications for US citizens. The trial raises important questions about the ethics of medical research and the need for greater transparency and accountability. It also highlights the importance of informed consent and the need for researchers to prioritize the safety and well-being of research participants.

The trial also has significant implications for the medical community. It highlights the need for greater scrutiny of medical research and the importance of prioritizing the safety and well-being of research participants. It also raises important questions about the role of funding agencies, such as the CDC, in promoting ethical research practices.

## Quotes & Reactions
"The WHO's condemnation of the trial is a wake-up call for the medical community," said **Dr. Maria Van Kerkhove**, a leading expert on vaccine safety. "It highlights the need for greater transparency and accountability in medical research, and the importance of prioritizing the safety and well-being of research participants."

"The trial is a classic example of the kind of exploitative research that has been perpetrated on vulnerable populations for far too long," said **Dr. Peter Hotez**, a leading expert on vaccine development. "It's a reminder that we need to do better, and that we need to prioritize the safety and well-being of research participants above all else."

## Outlook
The controversy surrounding the trial is likely to have significant implications for the medical community and for US citizens. It highlights the need for greater transparency and accountability in medical research, and the importance of prioritizing the safety and well-being of research participants.

In the coming weeks and months, we can expect to see a wider debate about the ethics of medical research and the need for greater scrutiny of medical trials. We can also expect to see increased calls for transparency and accountability, and a greater emphasis on prioritizing the safety and well-being of research participants.

As the debate continues to unfold, it's clear that the WHO's condemnation of the trial has sparked a important conversation about the ethics of medical research. It's a reminder that we need to do better, and that we need to prioritize the safety and well-being of research participants above all else. For more information on [vaccine effectiveness](/articles/top-us-medical-body-to-review-vaccine-effectiveness-as-government-abdicates-responsibility), please visit our website.

---
*Sources: Analysis based on reports from AP, Reuters, and [Original Story](https://news.google.com/rss/articles/CBMimgFBVV95cUxNNElOc0h0aG1Lck5tVUpRTTFnS2pEOEVxU2hndTl1UFpIYkU3NUZsZlFkNmRfdUh1dEdtS3l4NkN5Nld5N19EeWRuWUNTV2g1ZG1halJSUkVfR0x4YWJqODNVSElpM09SSzh1UGFKODJvLWQ2em1WSzFuSGhaOWl2WFIySnJoMHRuU29sNU9ZbkV4WGxfd09DaklR?oc=5).*
